KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Convertible Debt (2020 - 2025)

Guardant Health's Convertible Debt history spans 6 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Convertible Debt rose 31.64% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 31.64%, while the annual FY2025 figure was $1.5 billion, 31.64% up from the prior year.
  • Convertible Debt for Q4 2025 was $1.5 billion at Guardant Health, up from $1.1 billion in the prior quarter.
  • Across five years, Convertible Debt topped out at $1.5 billion in Q4 2025 and bottomed at $1.1 billion in Q3 2025.
  • The 5-year median for Convertible Debt is $1.1 billion (2022), against an average of $1.2 billion.
  • The largest annual shift saw Convertible Debt skyrocketed 40.75% in 2021 before it dropped 2.39% in 2025.
  • A 5-year view of Convertible Debt shows it stood at $1.1 billion in 2021, then rose by 0.23% to $1.1 billion in 2022, then rose by 0.23% to $1.1 billion in 2023, then rose by 0.23% to $1.1 billion in 2024, then surged by 31.64% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for GH's Convertible Debt are $1.5 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025).